190 related articles for article (PubMed ID: 30042316)
21. Quantification of Ataxin-3 and Ataxin-7 aggregates formed in vivo in Drosophila reveals a threshold of aggregated polyglutamine proteins associated with cellular toxicity.
Vinatier G; Corsi JM; Mignotte B; Gaumer S
Biochem Biophys Res Commun; 2015 Sep; 464(4):1060-1065. PubMed ID: 26210447
[TBL] [Abstract][Full Text] [Related]
22. Capturing the Conformational Ensemble of the Mixed Folded Polyglutamine Protein Ataxin-3.
Sicorello A; Różycki B; Konarev PV; Svergun DI; Pastore A
Structure; 2021 Jan; 29(1):70-81.e5. PubMed ID: 33065068
[TBL] [Abstract][Full Text] [Related]
23. Polyglutamine-Independent Features in Ataxin-3 Aggregation and Pathogenesis of Machado-Joseph Disease.
Carvalho AL; Silva A; Macedo-Ribeiro S
Adv Exp Med Biol; 2018; 1049():275-288. PubMed ID: 29427109
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the conformational fluctuations in the Josephin domain of ataxin-3.
Sanfelice D; De Simone A; Cavalli A; Faggiano S; Vendruscolo M; Pastore A
Biophys J; 2014 Dec; 107(12):2932-2940. PubMed ID: 25517158
[TBL] [Abstract][Full Text] [Related]
25. A novel nuclear DnaJ protein, DNAJC8, can suppress the formation of spinocerebellar ataxia 3 polyglutamine aggregation in a J-domain independent manner.
Ito N; Kamiguchi K; Nakanishi K; Sokolovskya A; Hirohashi Y; Tamura Y; Murai A; Yamamoto E; Kanaseki T; Tsukahara T; Kochin V; Chiba S; Shimohama S; Sato N; Torigoe T
Biochem Biophys Res Commun; 2016 Jun; 474(4):626-633. PubMed ID: 27133716
[TBL] [Abstract][Full Text] [Related]
26. Polyglutamine expansion diseases: More than simple repeats.
Silva A; de Almeida AV; Macedo-Ribeiro S
J Struct Biol; 2018 Feb; 201(2):139-154. PubMed ID: 28928079
[TBL] [Abstract][Full Text] [Related]
27. Mode of substrate recognition by the Josephin domain of ataxin-3, which has an endo-type deubiquitinase activity.
Satoh T; Sumiyoshi A; Yagi-Utsumi M; Sakata E; Sasakawa H; Kurimoto E; Yamaguchi Y; Li W; Joazeiro CA; Hirokawa T; Kato K
FEBS Lett; 2014 Nov; 588(23):4422-30. PubMed ID: 25448680
[TBL] [Abstract][Full Text] [Related]
28. The Machado-Joseph disease-associated expanded form of ataxin-3: Overexpression, purification, and preliminary biophysical and structural characterization.
Contessotto MGG; Rosselli-Murai LK; Garcia MCC; Oliveira CLP; Torriani IL; Lopes-Cendes I; Murai MJ
Protein Expr Purif; 2018 Dec; 152():40-45. PubMed ID: 30036587
[TBL] [Abstract][Full Text] [Related]
29. Destabilization of non-pathological variants of ataxin-3 by metal ions results in aggregation/fibrillogenesis.
Ricchelli F; Fusi P; Tortora P; Valtorta M; Riva M; Tognon G; Chieregato K; Bolognin S; Zatta P
Int J Biochem Cell Biol; 2007; 39(5):966-77. PubMed ID: 17300980
[TBL] [Abstract][Full Text] [Related]
30. Structural and functional analysis of the Josephin domain of the polyglutamine protein ataxin-3.
Chow MK; Mackay JP; Whisstock JC; Scanlon MJ; Bottomley SP
Biochem Biophys Res Commun; 2004 Sep; 322(2):387-94. PubMed ID: 15325242
[TBL] [Abstract][Full Text] [Related]
31. Towards a structural understanding of the fibrillization pathway in Machado-Joseph's disease: trapping early oligomers of non-expanded ataxin-3.
Gales L; Cortes L; Almeida C; Melo CV; Costa MC; Maciel P; Clarke DT; Damas AM; Macedo-Ribeiro S
J Mol Biol; 2005 Oct; 353(3):642-54. PubMed ID: 16194547
[TBL] [Abstract][Full Text] [Related]
32. Trifluoroethanol modulates amyloid formation by the all α-helical URN1 FF domain.
Marinelli P; Castillo V; Ventura S
Int J Mol Sci; 2013 Aug; 14(9):17830-44. PubMed ID: 23999589
[TBL] [Abstract][Full Text] [Related]
33. The two-stage pathway of ataxin-3 fibrillogenesis involves a polyglutamine-independent step.
Ellisdon AM; Thomas B; Bottomley SP
J Biol Chem; 2006 Jun; 281(25):16888-16896. PubMed ID: 16624810
[TBL] [Abstract][Full Text] [Related]
34. Understanding the role of the Josephin domain in the PolyUb binding and cleavage properties of ataxin-3.
Nicastro G; Todi SV; Karaca E; Bonvin AM; Paulson HL; Pastore A
PLoS One; 2010 Aug; 5(8):e12430. PubMed ID: 20865150
[TBL] [Abstract][Full Text] [Related]
35. Methacycline displays a strong efficacy in reducing toxicity in a SCA3 Caenorhabditis elegans model.
Amigoni L; Airoldi C; Natalello A; Romeo M; Diomede L; Tortora P; Regonesi ME
Biochim Biophys Acta Gen Subj; 2019 Feb; 1863(2):279-290. PubMed ID: 30420336
[TBL] [Abstract][Full Text] [Related]
36. Amyloidogenic potential of alpha-chymotrypsin in different conformational states.
Rezaei-Ghaleh N; Zweckstetter M; Morshedi D; Ebrahim-Habibi A; Nemat-Gorgani M
Biopolymers; 2009 Jan; 91(1):28-36. PubMed ID: 18767127
[TBL] [Abstract][Full Text] [Related]
37. Deubiquitinating function of ataxin-3: insights from the solution structure of the Josephin domain.
Mao Y; Senic-Matuglia F; Di Fiore PP; Polo S; Hodsdon ME; De Camilli P
Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12700-5. PubMed ID: 16118278
[TBL] [Abstract][Full Text] [Related]
38. A tale of a tail: Structural insights into the conformational properties of the polyglutamine protein ataxin-3.
Scarff CA; Sicorello A; Tomé RJ; Macedo-Ribeiro S; Ashcroft AE; Radford SE
Int J Mass Spectrom; 2013 Jul; 345-347():63-70. PubMed ID: 25844046
[TBL] [Abstract][Full Text] [Related]
39. The Josephin domain (JD) containing proteins are predicted to bind to the same interactors: Implications for spinocerebellar ataxia type 3 (SCA3) studies using
Sousa E Silva R; Sousa AD; Vieira J; Vieira CP
Front Mol Neurosci; 2023; 16():1140719. PubMed ID: 37008788
[TBL] [Abstract][Full Text] [Related]
40. A hydrophobic gold surface triggers misfolding and aggregation of the amyloidogenic Josephin domain in monomeric form, while leaving the oligomers unaffected.
Apicella A; Soncini M; Deriu MA; Natalello A; Bonanomi M; Dellasega D; Tortora P; Regonesi ME; Casari CS
PLoS One; 2013; 8(3):e58794. PubMed ID: 23527026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
